Sha** the future of cardiovascular disease by 3D printing applications in stent technology and its clinical outcomes

M Ullah, A Bibi, A Wahab, S Hamayun… - Current Problems in …, 2024 - Elsevier
Cardiovascular disease (CVD) is a leading cause of death worldwide. In recent years, 3D
printing technology has ushered in a new era of innovation in cardiovascular medicine. 3D …

Lipoprotein (a) in clinical practice: A guide for the clinician

C Krittanawong, NS Maitra, AH El-Sherbini… - Progress in …, 2023 - Elsevier
Cardiovascular disease (CVD) remains the leading cause of death worldwide. Serum
lipoprotein (a)(Lp (a)) has been shown to be an independent and causative risk factor for …

Remnant cholesterol and the risk of aortic valve calcium progression: insights from the MESA study

ZH Li, QY Hao, YH Zeng, JB Guo, SC Li… - Cardiovascular …, 2024 - Springer
Background Remnant cholesterol (RC) is implicated in the risk of cardiovascular disease.
However, comprehensive population-based studies elucidating its association with aortic …

Beyond Symptoms: Unlocking the Potential of Coronary Calcium Scoring in the Prevention and Treatment of Coronary Artery Disease.

T Abdul-Rahman, ZSB Bliss, I Lizano-Jubert… - Current Problems in …, 2024 - Elsevier
Abstract Coronary Artery Disease (CAD) represents a persistent global health menace,
particularly prevalent in Eastern European nations. Often asymptomatic until its advanced …

Exploring the significance of epicardial adipose tissue in aortic valve stenosis and left ventricular remodeling: Unveiling novel therapeutic and prognostic markers of …

S Quarta, G Santarpino, MA Carluccio, N Calabriso… - Vascular …, 2023 - Elsevier
Aortic stenosis (AS) is a dynamic degenerative process that shares many pathophysiological
features with atherogenesis, from initial proinflammatory calcification and focal thickening of …

[HTML][HTML] Age-Related Outcomes in Patients Undergoing Coronary Angiography: In Which Subgroups Does Age Matter? Results from a Large-Scale Retrospective …

L Kuhn, T Schupp, P Steinke, J Dudda… - Journal of Clinical …, 2025 - mdpi.com
Background: The study investigates age-related differences in the prevalence and extent of
coronary artery disease (CAD), as well as long-term outcomes in a large cohort of …

Gut Microbiome and Its Role in Valvular Heart Disease: Not a “Gutted” Relationship

G Nayak, K Dimitriadis, N Pyrpyris, M Manti… - Life, 2024 - mdpi.com
The role of the gut microbiome (GM) and oral microbiome (OM) in cardiovascular disease
(CVD) has been increasingly being understood in recent years. It is well known that GM is a …

Exploration and Validation of Immune and Therapeutic-Related Hub Genes in Aortic Valve Calcification and Carotid Atherosclerosis

KM Wei, Y Cao, XJ Kong, CZ Liu… - Journal of Inflammation …, 2024 - Taylor & Francis
Background Cardiovascular diseases, such as aortic valve calcification (AVC) and carotid
atherosclerosis (CAS), impose substantial health challenges on a global scale. Both …

Aldehyde dehydrogenase 2 rs671 a/A Genotype is Associated with an Increased Risk of Early Onset Coronary Artery Stenosis

H Rao, X Wang, Y Luo, L Liang, W Ye… - International Journal of …, 2024 - Taylor & Francis
Background The role of aldehyde dehydrogenase 2 (ALDH2) in cardiovascular diseases
has been gradually studied. However, it is unclear whether ALDH2 polymorphism is …

[HTML][HTML] Exploring the mediating role of calcium homeostasis in the association between diabetes mellitus, glycemic traits, and vascular and valvular calcifications: a …

XG Zhu, GQ Liu, YP Peng… - Diabetology & …, 2024 - dmsjournal.biomedcentral.com
The interplay between diabetes mellitus (DM), glycemic traits, and vascular and valvular
calcifications is intricate and multifactorial. Exploring potential mediators may illuminate …